OR-AKIVA, Israel, Aug. 9 /PRNewswire/ -- Deep Breeze(TM), the leader in vibration response imaging (VRI(TM)) technology, today announced that the U.S. Food and Drug Administration (FDA) granted 510K marketing clearance for the VRIXP(TM), a non-invasive, radiation-free pulmonary imaging system to use lung sounds to create dynamic images of the lungs.
